---
figid: PMC6274736__ijms-19-03295-g001
figtitle: Schematic diagram of c-mesenchymal–epithelial transition (c-MET) activation
  signaling pathways
organisms:
- NA
pmcid: PMC6274736
filename: ijms-19-03295-g001.jpg
figlink: /pmc/articles/PMC6274736/figure/ijms-19-03295-f001/
number: F1
caption: The schematic diagram of c-mesenchymal–epithelial transition (c-MET) activation
  signaling pathways. Activated c-MET binds adaptor molecules GRB-1 and GRB-2, and
  then they recruit Ras/Raf, SH2 containing protein tyrosine phosphatase (Shp2), STAT3/5,
  and PI3K signals. In addition, activation of other receptor tyrosine kinases (RTKs)
  signaling molecules (HER2, VEGFR, EGFR, and ALK) may cross-talk with the c-MET,
  further recruiting PI3K, ERK, and STAT3/5 signals. These downstream signals are
  involved in regulating cell morphogenesis, survival, proliferation, and invasion.
  Inhibition of the HGF/c-MET pathway can be achieved through c-MET kinase inhibitors
  (TKIs), anti-HGF monoclonal antibodies (Anti-HGF Ab), and anti-MET monoclonal antibodies
  (Anti-MET Ab). HGF, hepatocyte growth factor; ALK, anaplastic lymphoma kinase; JAK,
  Janus kinase; STAT3/5, signal transducers and activators of transcription 3/signal
  transducers and activators of transcription 5; HER2, human epidermal growth factor
  receptor 2; VEGFR, vascular endothelial growth factor receptor 2; EGFR, epidermal
  growth factor receptor; P, phosphorylation; GRB, growth factor receptor-bound protein;
  SOS, son of sevenless; Ras, GTPases and key transducers of receptor tyrosine kinase;
  Raf, raf kinase, effector of Ras; PI3K, phosphatidylinositide 3-kinases; AKT, protein
  kinase B; ERK, extracellular regulated protein kinases; MAPK, mitogen-activated
  protein kinase.
papertitle: 'HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers.'
reftext: Hongli Zhang, et al. Int J Mol Sci. 2018 Nov;19(11):3295.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9609096
figid_alias: PMC6274736__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6274736__F1
ndex: ecef5eb0-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6274736__ijms-19-03295-g001.html
  '@type': Dataset
  description: The schematic diagram of c-mesenchymal–epithelial transition (c-MET)
    activation signaling pathways. Activated c-MET binds adaptor molecules GRB-1 and
    GRB-2, and then they recruit Ras/Raf, SH2 containing protein tyrosine phosphatase
    (Shp2), STAT3/5, and PI3K signals. In addition, activation of other receptor tyrosine
    kinases (RTKs) signaling molecules (HER2, VEGFR, EGFR, and ALK) may cross-talk
    with the c-MET, further recruiting PI3K, ERK, and STAT3/5 signals. These downstream
    signals are involved in regulating cell morphogenesis, survival, proliferation,
    and invasion. Inhibition of the HGF/c-MET pathway can be achieved through c-MET
    kinase inhibitors (TKIs), anti-HGF monoclonal antibodies (Anti-HGF Ab), and anti-MET
    monoclonal antibodies (Anti-MET Ab). HGF, hepatocyte growth factor; ALK, anaplastic
    lymphoma kinase; JAK, Janus kinase; STAT3/5, signal transducers and activators
    of transcription 3/signal transducers and activators of transcription 5; HER2,
    human epidermal growth factor receptor 2; VEGFR, vascular endothelial growth factor
    receptor 2; EGFR, epidermal growth factor receptor; P, phosphorylation; GRB, growth
    factor receptor-bound protein; SOS, son of sevenless; Ras, GTPases and key transducers
    of receptor tyrosine kinase; Raf, raf kinase, effector of Ras; PI3K, phosphatidylinositide
    3-kinases; AKT, protein kinase B; ERK, extracellular regulated protein kinases;
    MAPK, mitogen-activated protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvr
  - ab
  - Appl
  - Egfr
  - Alk
  - Tie
  - Ras85D
  - InR
  - hop
  - bsk
  - mip120
  - MetRS
  - Glg1
  - MTA1-like
  - Pi3K92E
  - p120ctn
  - drk
  - Sos
  - pk
  - csw
  - Akt
  - ras
  - Ras64B
  - Raf
  - MKP-4
  - p38b
  - rl
  - Erk7
  - et
  - kis
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - ERBB2
  - KDR
  - FLT1
  - FLT4
  - HGF
  - IL6
  - SOS1
  - APP
  - SUCLA2
  - EGFR
  - ALK
  - MET
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - CTNND1
  - IGSF1
  - NOP2
  - RASA1
  - TRPA1
  - BRD8
  - NSUN5
  - GRB2
  - PIK3R1
  - XYLT2
  - SOS2
  - PTPN11
  - STAT5A
  - STAT5B
  - STAT3
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - UHMK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R2
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
